Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer

Update Il y a 4 ans
Reference: NCT00911092

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The scope of the trial is to predict the early complete clinical response to exclusive concomitant radiochemotherapy in esophageal cancer by the study of the pre- and per- therapeutic proteomic profile.


Inclusion criteria

  • Esophageal Cancer

Links